International Journal of Clinical Research

Objective To observe the efficacy and safety of bronchodilators and inhaled steroids in the treatment of patients with bronchiectasis. Methods A prospective study was conducted on 76 patients with bronchiectasis from April 2024 to August 2025. The patients were randomly divided into two groups using a digital table. The control group (38 cases) received conventional treatment, while the observation group (38 cases) received bronchodilators and inhaled steroids. Statistical analysis of patients' lung function, symptom improvement time, and adverse reactions. Results The lung function level in the observation group was higher than that in the control group after treatment, (P<0.05). The improvement time of symptoms in the observation group was shorter than that in the control group, (P<0.05). The incidence of adverse reactions showed no significant difference between the observation group and the control group, (P>0.05). Conclusion Treatment with bronchodilators and inhaled steroids for patients with bronchiectasis can improve various symptoms, promote the recovery of lung function, and does not increase the incidence of adverse reactions during treatment, ensuring the safety of the treatment process.

Bronchodilators; Inhalation of hormones; Bronchiectasia; Safety